Steris (STE) Free Cash Flow (QoQ) (2018 - 2026)
Steris (STE) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.19 Bn | 18.78 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.03% |
| Mar 31, 2026 | 22.91% |
| Dec 31, 2025 | -0.89% |
| Sep 30, 2025 | -38.33% |
| Jun 30, 2025 | 71.88% |
| Mar 31, 2025 | -22.04% |
| Dec 31, 2024 | 63.60% |
| Sep 30, 2024 | -23.88% |
| Jun 30, 2024 | 19.73% |
| Mar 31, 2024 | -5.19% |
| Dec 31, 2023 | 174.36% |
| Sep 30, 2023 | -70.73% |
| Jun 30, 2023 | 48.62% |
| Mar 31, 2023 | 26.89% |
| Dec 31, 2022 | 440.27% |
| Sep 30, 2022 | -81.82% |
| Jun 30, 2022 | 17.39% |
| Mar 31, 2022 | -39.54% |
| Dec 31, 2021 | 72.93% |
| Sep 30, 2021 | 130.00% |